BIENERTOVÁ VAŠKŮ, Julie, Petr BIENERT a Anna VAŠKŮ. Adiponectin, its cardioprotective effects and genetic variability in relation to restenosis after percutaneous coronary intervention (PCI). In Adiponectin: Production, Regulation and Roles in Disease. New York: Nova Science Publishers, 2012, s. 23-38. Endocrinology Research and Clinical Developments. ISBN 978-1-61942-165-3.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Adiponectin, its cardioprotective effects and genetic variability in relation to restenosis after percutaneous coronary intervention (PCI)
Autoři BIENERTOVÁ VAŠKŮ, Julie (203 Česká republika, garant, domácí), Petr BIENERT (203 Česká republika, domácí) a Anna VAŠKŮ (203 Česká republika, domácí).
Vydání New York, Adiponectin: Production, Regulation and Roles in Disease, od s. 23-38, 16 s. Endocrinology Research and Clinical Developments, 2012.
Nakladatel Nova Science Publishers
Další údaje
Originální jazyk angličtina
Typ výsledku Kapitola resp. kapitoly v odborné knize
Obor 30201 Cardiac and Cardiovascular systems
Stát vydavatele Spojené státy
Utajení není předmětem státního či obchodního tajemství
Forma vydání tištěná verze "print"
Kód RIV RIV/00216224:14110/12:00060425
Organizační jednotka Lékařská fakulta
ISBN 978-1-61942-165-3
Klíčová slova anglicky adiponectin; percutaneous coronary intervention; restenosis; polymorphism
Změnil Změnila: Ing. Mgr. Věra Pospíšilíková, učo 9005. Změněno: 10. 4. 2013 16:01.
Anotace
Restenosis after percutaneous coronary intervention (PCI) represents a major limitation to this procedure and despite large efforts it is still difficult to stratify patients after PCI according to restenosis risk. A wide range of proteins have been investigated in order to establish new diagnostic/prognostic markers of restenosis after PCI, without major effects. Adiponectin, a protein secreted exclusively by the adipose tissue, has recently emerged as an anti-inflammatory, anti-atherogenic, insulin-sensitizing factor providing possible link between white adipose tissue and cardiovascular disease. This crucial role in cardioprotection is mediated via a variety of mechanisms, including inhibition of foam cell formation, expression of antithrombogenic properties and inhibition of smooth muscle cells proliferation, all vital processes in restenosis development. Considering its cardioprotective effects, the role of adiponectin in prediction of adverse cardiovascular events has been studied extensively. However, little attention is paid to adiponectin role in restenosis development after PCI, even though pathophysiology of restenosis covers directly the mechanisms regulated or substantially influenced by adiponectin. The current review describes pathophysiological effects of adiponectin in cardiovascular system, mainly those closely associated with restenosis development and attention is being paid also to the role of genetic variability.
Anotace česky
Adiponektin a jeho kardioprotektivní účinky.
VytisknoutZobrazeno: 18. 6. 2024 22:30